ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:ABT • US0028241000
109.02 USD
-0.39 (-0.36%)
At close: Feb 3, 2026
108.82 USD
-0.2 (-0.18%)
Pre-Market: 2/4/2026, 7:10:14 AM
Taking everything into account, ABT scores 6 out of 10 in our fundamental rating. ABT was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While ABT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABT has a decent growth rate and is not valued too expensively. ABT also has an excellent dividend rating. These ratings would make ABT suitable for dividend investing!
1. Profitability
1.1 Basic Checks
- In the past year ABT was profitable.
- In the past year ABT had a positive cash flow from operations.
- In the past 5 years ABT has always been profitable.
- Of the past 5 years ABT 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 16.60%, ABT belongs to the top of the industry, outperforming 97.31% of the companies in the same industry.
- ABT's Return On Equity of 27.43% is amongst the best of the industry. ABT outperforms 98.39% of its industry peers.
- With an excellent Return On Invested Capital value of 8.88%, ABT belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 31.88%, ABT belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
- In the last couple of years the Profit Margin of ABT has grown nicely.
- ABT's Operating Margin of 18.29% is amongst the best of the industry. ABT outperforms 89.78% of its industry peers.
- ABT's Operating Margin has improved in the last couple of years.
- ABT's Gross Margin of 56.19% is in line compared to the rest of the industry. ABT outperforms 55.38% of its industry peers.
- In the last couple of years the Gross Margin of ABT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- ABT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- There is no outstanding debt for ABT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- ABT has an Altman-Z score of 5.22. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.22, ABT is doing good in the industry, outperforming 78.49% of the companies in the same industry.
- The Debt to FCF ratio of ABT is 1.87, which is an excellent value as it means it would take ABT, only 1.87 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 1.87, ABT belongs to the best of the industry, outperforming 87.63% of the companies in the same industry.
- A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
- ABT has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: ABT outperforms 56.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.22 |
ROIC/WACC0.88
WACC10.07%
2.3 Liquidity
- ABT has a Current Ratio of 1.70. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- ABT has a worse Current ratio (1.70) than 67.74% of its industry peers.
- A Quick Ratio of 1.24 indicates that ABT should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.24, ABT is doing worse than 65.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- Measured over the past 5 years, ABT shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
- ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
- Measured over the past years, ABT shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- ABT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.18% yearly.
- Based on estimates for the next years, ABT will show a small growth in Revenue. The Revenue will grow by 7.15% on average per year.
EPS Next Y11.35%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
EPS Next 5Y10.18%
Revenue Next Year7.19%
Revenue Next 2Y7.26%
Revenue Next 3Y7.21%
Revenue Next 5Y7.15%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 21.17, which indicates a rather expensive current valuation of ABT.
- 82.26% of the companies in the same industry are more expensive than ABT, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 28.18, ABT is valued a bit cheaper.
- ABT is valuated rather expensively with a Price/Forward Earnings ratio of 19.01.
- ABT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 82.80% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.51. ABT is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.17 | ||
| Fwd PE | 19.01 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 80.11% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, ABT is valued cheaper than 81.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.41 | ||
| EV/EBITDA | 17.45 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABT does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.87
PEG (5Y)2.97
EPS Next 2Y10.76%
EPS Next 3Y9.84%
5. Dividend
5.1 Amount
- ABT has a Yearly Dividend Yield of 2.38%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.21, ABT pays a better dividend. On top of this ABT pays more dividend than 97.85% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, ABT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
5.2 History
- The dividend of ABT is nicely growing with an annual growth rate of 11.40%!
- ABT has paid a dividend for at least 10 years, which is a reliable track record.
- ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
5.3 Sustainability
- ABT pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- The dividend of ABT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
109.02
-0.39 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.33%
Inst Owner Change-1.77%
Ins Owners0.45%
Ins Owner Change-0.06%
Market Cap189.57B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts79.43
Price Target146.96 (34.8%)
Short Float %1.15%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15 2026-01-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)0.1%
PT rev (3m)0.07%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.71%
Revenue NY rev (3m)-0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.17 | ||
| Fwd PE | 19.01 | ||
| P/S | 4.32 | ||
| P/FCF | 27.41 | ||
| P/OCF | 20.79 | ||
| P/B | 3.72 | ||
| P/tB | 8.86 | ||
| EV/EBITDA | 17.45 |
EPS(TTM)5.15
EY4.72%
EPS(NY)5.73
Fwd EY5.26%
FCF(TTM)3.98
FCFY3.65%
OCF(TTM)5.24
OCFY4.81%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)1.87
PEG (5Y)2.97
Graham Number58.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.22 |
F-Score8
WACC10.07%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.35%
EPS Next 2Y10.76%
EPS Next 3Y9.84%
EPS Next 5Y10.18%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7.19%
Revenue Next 2Y7.26%
Revenue Next 3Y7.21%
Revenue Next 5Y7.15%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y14.39%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABT FAQ
What is the fundamental rating for ABT stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABT.
What is the valuation status of ABBOTT LABORATORIES (ABT) stock?
ChartMill assigns a valuation rating of 6 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
What is the profitability of ABT stock?
ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.17 and the Price/Book (PB) ratio is 3.72.
Can you provide the expected EPS growth for ABT stock?
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.35% in the next year.